Operating Margin in % of Lyra Therapeutics, Inc. from 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lyra Therapeutics, Inc. quarterly/annual Operating Margin history and change rate from 2021 to Q3 2025.
  • Lyra Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -5.89K %, a 14.6% increase year-over-year.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2024 was -6.28K %, a 45.8% decline from 2023.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2023 was -4.31K %, a 4.29% decline from 2022.
  • Lyra Therapeutics, Inc. annual Operating Margin for 2022 was -4.13K %, a 73% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Lyra Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -5.89K +1.01K +14.6% 01 Jul 2025 30 Sep 2025
Q2 2025 -5.39K +421 +7.25% 01 Apr 2025 30 Jun 2025
Q1 2025 -6.89K -2.53K -57.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -6.28K -1.97K -45.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -6.89K -2.27K -49.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -5.81K -660 -12.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -4.36K +363 +7.67% 01 Jan 2024 31 Mar 2024
Q4 2023 -4.31K -177 -4.29% 01 Oct 2023 31 Dec 2023
Q3 2023 -4.62K 01 Jul 2023 30 Sep 2023
Q2 2023 -5.15K 01 Apr 2023 30 Jun 2023
Q1 2023 -4.73K 01 Jan 2023 31 Mar 2023
Q4 2022 -4.13K 01 Oct 2022 31 Dec 2022

Lyra Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -6.28K -1.97K -45.8% 01 Jan 2024 31 Dec 2024
2023 -4.31K -177 -4.29% 01 Jan 2023 31 Dec 2023
2022 -4.13K +11.2K +73% 01 Jan 2022 31 Dec 2022
2021 -15.3K 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.